HFpEF and glycemic variability: GHIDD Trial
Anno:
2024
BACKGROUND: Recently the guidelines of European Association of Preventive Cardiology reported that the prevalence of diabetes mellitus in patients with diastolic heart failure (HFpEF) is around 31%. POURPOSE: In our study we evaluated the non diabetic patients with HFpEF with Glunovo® to evaluate the glycaemic variability in this population…